Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Lexaria Bioscience Corp
(NQ:
LEXX
)
3.270
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Lexaria Bioscience Corp
< Previous
1
2
3
4
5
Next >
$1M Bet On Glatfelter? Check Out These 4 Penny Stocks Insiders Are Buying
February 28, 2023
The Dow Jones closed lower by over 70 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested...
Via
Benzinga
Lexaria Discovers Potential Novel Mechanism From Hypertension Study Of Processed CBD
February 21, 2023
Via
Benzinga
This BioTech Company Using CBD For Enhanced Hypertension Treatment Could Be One To Watch
November 07, 2022
Lexaria Bioscience Corp.
Via
Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 10, 2022
Via
Benzinga
Lexaria Gets FDA's Positive Feedback On Pre-Clinical Trial Of Hypertension Candidate
August 10, 2022
Lexaria Bioscience Corp. (NASDAQ: LEXX) announced that it has received a positive full written response from the Food and Drug Administration (FDA) from its pre-Investigational New Drug meeting...
Via
Benzinga
Lexaria Bioscience' Tech Processed Cannabidiol Receives Positive FDA Feedback For Hypertension
August 10, 2022
Via
Benzinga
Lexaria Posied To Receive US Patent For DehydraTECH To Deliver Antiviral Drugs
April 21, 2022
Via
Benzinga
Why Is Lexaria Bioscience (LEXX) Stock Up Today?
April 14, 2022
Today, investors in Lexaria Bioscience and LEXX stock are seeing impressive gains as investors price a key catalyst into shares.
Via
InvestorPlace
Why Lexaria Shares Are Rising Today
April 14, 2022
Via
Benzinga
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
July 27, 2022
Via
Benzinga
Lexaria's DehydraTECH CBD Hypertension Study Dosing Complete With No Serious Adverse Events
July 27, 2022
Lexaria Bioscience Corp. (NASDAQ: LEXX) (NASDAQ: LEXXW) revealed that dosing with Lexaria's DehydraTECH-processed CBD has been completed in its multi-week human clinical hypertension study HYPER-H21-4
Via
Benzinga
Nasdaq Rises 2.5%; ACADIA Pharmaceuticals Shares Plummet
June 21, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 2.5% on Tuesday.
Via
Benzinga
Why Shares Of Lexaria Biosciences Are Trading Higher
June 21, 2022
Lexaria Bioscience Corp. (NASDAQ: LEXX) shares are trading higher after the company announced manufacturing and license agreements with BevNology.
Via
Benzinga
Dow Jumps 550 Points; Convey Health Solutions Shares Spike Higher
June 21, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 550 points on Tuesday.
Via
Benzinga
67 Biggest Movers From Yesterday
June 22, 2022
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.
Via
Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
June 21, 2022
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.
Via
Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Advancing DehydraTECH-Nicotine Research
April 26, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Lexaria expects to begin dosing this summer as part of a human...
Via
Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Secures Patent For DehydraTECH To Deliver Antivirals
April 22, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
53 Biggest Movers From Yesterday
April 21, 2022
Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded a five-year contract by Brunei Shell Petroleum...
Via
Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Commences Its Most Comprehensive Study To Date
April 20, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
28 Stocks Moving In Wednesday's Mid-Day Session
April 20, 2022
Gainers Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) climbed 58.3% to $2.2950 after jumping around 22% on Tuesday. AlloVir, Inc. (NASDAQ: ALVR) shares climbed 39% to $7.52...
Via
Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Announces Positive Results From Hypertension Study
April 18, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 14, 2022
Gainers
Via
Benzinga
51 Biggest Movers From Thursday
April 18, 2022
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of...
Via
Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Issues Update On Human Nicotine Study
April 13, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Begins Nicotine Formulation Creation, Evaluation Program
April 12, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Lexaria Aims To Demonstrate DehydraTECH's Performance In Epilepsy Research
April 11, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Lexaria Bioscience's 24th Patent Sets Stage For Market Opportunities In Australia
March 31, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Lexaria Bioscience Optimistic About Upcoming Hypertension Study
March 28, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Lexaria's IP Portfolio Grows Following Receipt Of 24th Granted Patent
March 22, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Lexaria has received a new patent entitled “Compositions...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.